Glucotrack (GCTK) Total Non-Current Liabilities (2012 - 2025)

Glucotrack has disclosed Total Non-Current Liabilities across 14 years of filings, most recently posting $4.8 million for Q4 2025.

• Quarterly Total Non-Current Liabilities rose 216.28% year-over-year to $4.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.8 million (up 216.28% YoY) and the FY2025 annual result came in at $4.8 million, up 216.28% from the prior year.
• Total Non-Current Liabilities eased to $4.8 million in Q4 2025, from $5.5 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $5.5 million in Q3 2025 and troughed at $184000.0 in Q3 2023.
• A 5-year average of $1.6 million and a median of $235000.0 in 2021 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2021 — Total Non-Current Liabilities sank 42.54% — and 2024, when it jumped 2514.67%.
• Tracing GCTK's Total Non-Current Liabilities over 5 years: stood at $227000.0 in 2021, then retreated by 14.1% to $195000.0 in 2022, then surged by 675.38% to $1.5 million in 2023, then slipped by 0.07% to $1.5 million in 2024, then jumped by 216.28% to $4.8 million in 2025.
• Business Quant data shows GCTK's Total Non-Current Liabilities at $4.8 million in Q4 2025, $5.5 million in Q3 2025, and $3.3 million in Q2 2025.